Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 May;115(2):330–334. doi: 10.1111/j.1476-5381.1995.tb15881.x

Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria.

C Chulak 1, R Couture 1, S Foucart 1
PMCID: PMC1908333  PMID: 7670735

Abstract

1. We investigated the modulation by bradykinin (BK) of electrically induced noradrenaline release in rat isolated atria preincubated with [3H]-noradrenaline. 2. BK (1-100 nM) enhanced significantly the stimulation-induced outflow of radioactivity in a concentration-dependent manner with a calculated EC50 of 0.58 nM. 3. Des-Arg9-BK (0.1-100 nM), a selective B1 receptor agonist, did not modify the stimulation-induced outflow of radioactivity. Hoe 140 (10 nM), a selective B2 receptor antagonist, but not [Leu8]-des-Arg9-BK (100 nM), a selective B1 receptor antagonist, blocked the facilitatory effect of BK. 4. The effect of BK was not affected by diclofenac (1 microM), a cyclo-oxygenase inhibitor. Bisindolylmaleimide (1 microM), a protein kinase C inhibitor, significantly reduced the facilitatory effect of BK (10 nM), angiotensin II (0.3 microM) and phorbol dibutyrate (0.1 and 1 microM) but not of fenoterol (1 microM). 5. The results suggest that BK enhances noradrenaline release via a prejunctional B2 kinin receptor in the rat atrium. The effect appears to involve protein kinase C as a second messenger.

Full text

PDF
330

Images in this article

332Figure 3
on p.332
332Figure 4
on p.332
332Figure 5
on p.332

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allgaier C., Hertting G. Polymyxin B, a selective inhibitor of protein kinase C, diminishes the release of noradrenaline and the enhancement of release caused by phorbol 12,13-butyrate. Naunyn Schmiedebergs Arch Pharmacol. 1986 Oct;334(2):218–221. doi: 10.1007/BF00505825. [DOI] [PubMed] [Google Scholar]
  2. Balfagon G., Rosa de Sagarra M., Barrus M. T., Arrivas S., Capilla M. I., Marin J. Effect of phorbol esters on noradrenaline release from cerebral arteries. Brain Res. 1989 Jan 16;477(1-2):196–201. doi: 10.1016/0006-8993(89)91407-8. [DOI] [PubMed] [Google Scholar]
  3. Calixto J. B., Medeiros Y. S. Characterization of bradykinin mediating pertussis toxin-insensitive biphasic response in circular muscle of the isolated guinea pig ileum. J Pharmacol Exp Ther. 1991 Nov;259(2):659–665. [PubMed] [Google Scholar]
  4. Calixto J. B., Medeiros Y. S. Effect of protein kinase C and calcium on bradykinin-mediated contractions of rabbit vessels. Hypertension. 1992 Feb;19(2 Suppl):II87–II93. doi: 10.1161/01.hyp.19.2_suppl.ii87. [DOI] [PubMed] [Google Scholar]
  5. Deblois D., Bouthillier J., Marceau F. Effect of glucocorticoids, monokines and growth factors on the spontaneously developing responses of the rabbit isolated aorta to des-Arg9-bradykinin. Br J Pharmacol. 1988 Apr;93(4):969–977. doi: 10.1111/j.1476-5381.1988.tb11487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dominiak P., Simon M., Blöchl A., Brenner P. Changes in peripheral sympathetic outflow of pithed spontaneously hypertensive rats after bradykinin and DesArg-bradykinin infusions: influence of converting-enzyme inhibition. J Cardiovasc Pharmacol. 1992;20 (Suppl 9):S35–S38. doi: 10.1097/00005344-199200209-00008. [DOI] [PubMed] [Google Scholar]
  7. Hall J. M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther. 1992 Nov;56(2):131–190. doi: 10.1016/0163-7258(92)90016-s. [DOI] [PubMed] [Google Scholar]
  8. Hess J. F., Borkowski J. A., Stonesifer G. Y., MacNeil T., Strader C. D., Ransom R. W. Cloning and pharmacological characterization of bradykinin receptors. Braz J Med Biol Res. 1994 Aug;27(8):1725–1731. [PubMed] [Google Scholar]
  9. Hock F. J., Wirth K., Albus U., Linz W., Gerhards H. J., Wiemer G., Henke S., Breipohl G., König W., Knolle J. Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol. 1991 Mar;102(3):769–773. doi: 10.1111/j.1476-5381.1991.tb12248.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ishac E. J., De Luca A. The influence of activation or inhibition of protein kinase C on the release of radioactivity from rat isolated atria labelled with [3H]-noradrenaline. Br J Pharmacol. 1988 Jul;94(3):713–720. doi: 10.1111/j.1476-5381.1988.tb11580.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Johnston H., Majewski H., Musgrave I. F. Involvement of cyclic nucleotides in prejunctional modulation of noradrenaline release in mouse atria. Br J Pharmacol. 1987 Aug;91(4):773–781. doi: 10.1111/j.1476-5381.1987.tb11275.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lembeck F., Griesbacher T., Eckhardt M., Henke S., Breipohl G., Knolle J. New, long-acting, potent bradykinin antagonists. Br J Pharmacol. 1991 Feb;102(2):297–304. doi: 10.1111/j.1476-5381.1991.tb12169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Llona I., Galleguillos X., Belmar J., Huidobro-Toro J. P. Bradykinin modulates the release of noradrenaline from vas deferens nerve terminals. Life Sci. 1991;48(26):2585–2592. doi: 10.1016/0024-3205(91)90616-j. [DOI] [PubMed] [Google Scholar]
  14. Marceau F., Lussier A., Regoli D., Giroud J. P. Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharmacol. 1983;14(2):209–229. doi: 10.1016/0306-3623(83)90001-0. [DOI] [PubMed] [Google Scholar]
  15. Menke J. G., Borkowski J. A., Bierilo K. K., MacNeil T., Derrick A. W., Schneck K. A., Ransom R. W., Strader C. D., Linemeyer D. L., Hess J. F. Expression cloning of a human B1 bradykinin receptor. J Biol Chem. 1994 Aug 26;269(34):21583–21586. [PubMed] [Google Scholar]
  16. Minshall R. D., Yelamanchi V. P., Djokovic A., Miletich D. J., Erdös E. G., Rabito S. F., Vogel S. M. Importance of sympathetic innervation in the positive inotropic effects of bradykinin and ramiprilat. Circ Res. 1994 Mar;74(3):441–447. doi: 10.1161/01.res.74.3.441. [DOI] [PubMed] [Google Scholar]
  17. Musgrave I. F., Foucart S., Majewski H. Evidence that angiotensin II enhances noradrenaline release from sympathetic nerves in mouse atria by activating protein kinase C. J Auton Pharmacol. 1991 Aug;11(4):211–220. doi: 10.1111/j.1474-8673.1991.tb00319.x. [DOI] [PubMed] [Google Scholar]
  18. Nakhostine N., Ribuot C., Lamontagne D., Nadeau R., Couture R. Mediation by B1 and B2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br J Pharmacol. 1993 Sep;110(1):71–76. doi: 10.1111/j.1476-5381.1993.tb13773.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Starke K., Peskar B. A., Schumacher K. A., Taube H. D. Bradykinin and postganglionic sympathetic transmission. Naunyn Schmiedebergs Arch Pharmacol. 1977 Aug;299(1):23–32. doi: 10.1007/BF00508633. [DOI] [PubMed] [Google Scholar]
  20. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  21. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem Biophys Res Commun. 1986 Mar 13;135(2):397–402. doi: 10.1016/0006-291x(86)90008-2. [DOI] [PubMed] [Google Scholar]
  22. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 1991 Aug 25;266(24):15771–15781. [PubMed] [Google Scholar]
  23. Tsuda K., Tsuda S., Goldstein M., Nishio I., Masuyama Y. Effects of bradykinin on [3H]-norepinephrine release in rat hypothalamus. Clin Exp Pharmacol Physiol. 1993 Dec;20(12):787–791. doi: 10.1111/j.1440-1681.1993.tb03016.x. [DOI] [PubMed] [Google Scholar]
  24. Wakade A. R., Malhotra R. K., Wakade T. D. Phorbol ester, an activator of protein kinase C, enhances calcium-dependent release of sympathetic neurotransmitter. Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):122–124. doi: 10.1007/BF00498863. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES